The Market Reports

Index

1 Acute Migraine Drugs Market Overview
1.1 Product Overview and Scope of Acute Migraine Drugs
1.2 Acute Migraine Drugs Segment by Type
1.2.1 Global Acute Migraine Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Triptans
1.2.3 NSAIDs
1.2.4 Others
1.3 Acute Migraine Drugs Segment by Application
1.3.1 Global Acute Migraine Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.4 Global Acute Migraine Drugs Market Size Estimates and Forecasts
1.4.1 Global Acute Migraine Drugs Revenue 2016-2027
1.4.2 Global Acute Migraine Drugs Sales 2016-2027
1.4.3 Acute Migraine Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Acute Migraine Drugs Market Competition by Manufacturers
2.1 Global Acute Migraine Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Acute Migraine Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Acute Migraine Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Acute Migraine Drugs Manufacturing Sites, Area Served, Product Type
2.5 Acute Migraine Drugs Market Competitive Situation and Trends
2.5.1 Acute Migraine Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Acute Migraine Drugs Players Market Share by Revenue
2.5.3 Global Acute Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Acute Migraine Drugs Retrospective Market Scenario by Region
3.1 Global Acute Migraine Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Acute Migraine Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Acute Migraine Drugs Market Facts & Figures by Country
3.3.1 North America Acute Migraine Drugs Sales by Country
3.3.2 North America Acute Migraine Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Acute Migraine Drugs Market Facts & Figures by Country
3.4.1 Europe Acute Migraine Drugs Sales by Country
3.4.2 Europe Acute Migraine Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Acute Migraine Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Acute Migraine Drugs Sales by Region
3.5.2 Asia Pacific Acute Migraine Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Acute Migraine Drugs Market Facts & Figures by Country
3.6.1 Latin America Acute Migraine Drugs Sales by Country
3.6.2 Latin America Acute Migraine Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Acute Migraine Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Acute Migraine Drugs Sales by Country
3.7.2 Middle East and Africa Acute Migraine Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Acute Migraine Drugs Historic Market Analysis by Type
4.1 Global Acute Migraine Drugs Sales Market Share by Type (2016-2021)
4.2 Global Acute Migraine Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Acute Migraine Drugs Price by Type (2016-2021)

5 Global Acute Migraine Drugs Historic Market Analysis by Application
5.1 Global Acute Migraine Drugs Sales Market Share by Application (2016-2021)
5.2 Global Acute Migraine Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Acute Migraine Drugs Price by Application (2016-2021)

6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 GSK Acute Migraine Drugs Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Teva Acute Migraine Drugs Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Pfizer Acute Migraine Drugs Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Novartis Acute Migraine Drugs Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Sun Pharma
6.5.1 Sun Pharma Corporation Information
6.5.2 Sun Pharma Description and Business Overview
6.5.3 Sun Pharma Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Sun Pharma Acute Migraine Drugs Product Portfolio
6.5.5 Sun Pharma Recent Developments/Updates
6.6 Grunenthal
6.6.1 Grunenthal Corporation Information
6.6.2 Grunenthal Description and Business Overview
6.6.3 Grunenthal Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Grunenthal Acute Migraine Drugs Product Portfolio
6.6.5 Grunenthal Recent Developments/Updates
6.7 Endo Pharmaceuticals
6.6.1 Endo Pharmaceuticals Corporation Information
6.6.2 Endo Pharmaceuticals Description and Business Overview
6.6.3 Endo Pharmaceuticals Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Endo Pharmaceuticals Acute Migraine Drugs Product Portfolio
6.7.5 Endo Pharmaceuticals Recent Developments/Updates
6.8 Merck
6.8.1 Merck Corporation Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Merck Acute Migraine Drugs Product Portfolio
6.8.5 Merck Recent Developments/Updates
6.9 J & J
6.9.1 J & J Corporation Information
6.9.2 J & J Description and Business Overview
6.9.3 J & J Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
6.9.4 J & J Acute Migraine Drugs Product Portfolio
6.9.5 J & J Recent Developments/Updates

7 Acute Migraine Drugs Manufacturing Cost Analysis
7.1 Acute Migraine Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Acute Migraine Drugs
7.4 Acute Migraine Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Acute Migraine Drugs Distributors List
8.3 Acute Migraine Drugs Customers

9 Acute Migraine Drugs Market Dynamics
9.1 Acute Migraine Drugs Industry Trends
9.2 Acute Migraine Drugs Growth Drivers
9.3 Acute Migraine Drugs Market Challenges
9.4 Acute Migraine Drugs Market Restraints

10 Global Market Forecast
10.1 Acute Migraine Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Acute Migraine Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Acute Migraine Drugs by Type (2022-2027)
10.2 Acute Migraine Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Acute Migraine Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Acute Migraine Drugs by Application (2022-2027)
10.3 Acute Migraine Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Acute Migraine Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Acute Migraine Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Acute Migraine Drugs Sales (K Unit) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Acute Migraine Drugs Sales (K Unit) Comparison by Application (2021-2027)
Table 3. Global Acute Migraine Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Acute Migraine Drugs Covered in This Study
Table 5. Global Acute Migraine Drugs Sales (K Unit) of Key Manufacturers (2016-2021)
Table 6. Global Acute Migraine Drugs Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Acute Migraine Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Acute Migraine Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Acute Migraine Drugs Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Acute Migraine Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Acute Migraine Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Acute Migraine Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Migraine Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Acute Migraine Drugs Sales by Region (2016-2021) & (K Unit)
Table 16. Global Acute Migraine Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Acute Migraine Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit)
Table 19. North America Acute Migraine Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Acute Migraine Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Acute Migraine Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit)
Table 23. Europe Acute Migraine Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Acute Migraine Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Acute Migraine Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Acute Migraine Drugs Sales by Region (2016-2021) & (K Unit)
Table 27. Asia Pacific Acute Migraine Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Acute Migraine Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Acute Migraine Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit)
Table 31. Latin America Acute Migraine Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Acute Migraine Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Acute Migraine Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit)
Table 35. Middle East and Africa Acute Migraine Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Acute Migraine Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Acute Migraine Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Acute Migraine Drugs Sales (K Unit) by Type (2016-2021)
Table 39. Global Acute Migraine Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Acute Migraine Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Acute Migraine Drugs Revenue Share by Type (2016-2021)
Table 42. Global Acute Migraine Drugs Price (USD/Unit) by Type (2016-2021)
Table 43. Global Acute Migraine Drugs Sales (K Unit) by Application (2016-2021)
Table 44. Global Acute Migraine Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Acute Migraine Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Acute Migraine Drugs Revenue Share by Application (2016-2021)
Table 47. Global Acute Migraine Drugs Price (USD/Unit) by Application (2016-2021)
Table 48. GSK Corporation Information
Table 49. GSK Description and Business Overview
Table 50. GSK Acute Migraine Drugs Sales (K Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. GSK Acute Migraine Drugs Product
Table 52. GSK Recent Developments/Updates
Table 53. Teva Corporation Information
Table 54. Teva Description and Business Overview
Table 55. Teva Acute Migraine Drugs Sales (K Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Teva Acute Migraine Drugs Product
Table 57. Teva Recent Developments/Updates
Table 58. Pfizer Corporation Information
Table 59. Pfizer Description and Business Overview
Table 60. Pfizer Acute Migraine Drugs Sales (K Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Pfizer Acute Migraine Drugs Product
Table 62. Pfizer Recent Developments/Updates
Table 63. Novartis Corporation Information
Table 64. Novartis Description and Business Overview
Table 65. Novartis Acute Migraine Drugs Sales (K Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Novartis Acute Migraine Drugs Product
Table 67. Novartis Recent Developments/Updates
Table 68. Sun Pharma Corporation Information
Table 69. Sun Pharma Description and Business Overview
Table 70. Sun Pharma Acute Migraine Drugs Sales (K Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Sun Pharma Acute Migraine Drugs Product
Table 72. Sun Pharma Recent Developments/Updates
Table 73. Grunenthal Corporation Information
Table 74. Grunenthal Description and Business Overview
Table 75. Grunenthal Acute Migraine Drugs Sales (K Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Grunenthal Acute Migraine Drugs Product
Table 77. Grunenthal Recent Developments/Updates
Table 78. Endo Pharmaceuticals Corporation Information
Table 79. Endo Pharmaceuticals Description and Business Overview
Table 80. Endo Pharmaceuticals Acute Migraine Drugs Sales (K Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Endo Pharmaceuticals Acute Migraine Drugs Product
Table 82. Endo Pharmaceuticals Recent Developments/Updates
Table 83. Merck Corporation Information
Table 84. Merck Description and Business Overview
Table 85. Merck Acute Migraine Drugs Sales (K Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Merck Acute Migraine Drugs Product
Table 87. Merck Recent Developments/Updates
Table 88. J & J Corporation Information
Table 89. J & J Description and Business Overview
Table 90. J & J Acute Migraine Drugs Sales (K Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. J & J Acute Migraine Drugs Product
Table 92. J & J Recent Developments/Updates
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Acute Migraine Drugs Distributors List
Table 96. Acute Migraine Drugs Customers List
Table 97. Acute Migraine Drugs Market Trends
Table 98. Acute Migraine Drugs Growth Drivers
Table 99. Acute Migraine Drugs Market Challenges
Table 100. Acute Migraine Drugs Market Restraints
Table 101. Global Acute Migraine Drugs Sales Forecast by Type (2022-2027) & (K Unit)
Table 102. Global Acute Migraine Drugs Sales Market Share Forecast by Type (2022-2027)
Table 103. Global Acute Migraine Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 104. Global Acute Migraine Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 105. Global Acute Migraine Drugs Sales Forecast by Application (2022-2027) & (K Unit)
Table 106. Global Acute Migraine Drugs Sales Market Share Forecast by Application (2022-2027)
Table 107. Global Acute Migraine Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 108. Global Acute Migraine Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 109. Global Acute Migraine Drugs Sales Forecast by Region (2022-2027) & (K Unit)
Table 110. Global Acute Migraine Drugs Sales Market Share Forecast by Region (2022-2027)
Table 111. Global Acute Migraine Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 112. Global Acute Migraine Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Acute Migraine Drugs
Figure 2. Global Acute Migraine Drugs Market Share by Type in 2020 & 2027
Figure 3. Triptans Product Picture
Figure 4. NSAIDs Product Picture
Figure 5. Others Product Picture
Figure 6. Global Acute Migraine Drugs Market Share by Application in 2020 & 2027
Figure 7. Hospital Pharmacies
Figure 8. Drug Stores
Figure 9. Global Acute Migraine Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Acute Migraine Drugs Market Size 2016-2027 (US$ Million)
Figure 11. Global Acute Migraine Drugs Sales 2016-2027 (K Unit)
Figure 12. Global Acute Migraine Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Acute Migraine Drugs Sales Share by Manufacturers in 2020
Figure 14. Global Acute Migraine Drugs Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Acute Migraine Drugs Players: Market Share by Revenue in 2020
Figure 16. Acute Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Acute Migraine Drugs Sales Market Share by Region (2016-2021)
Figure 18. Global Acute Migraine Drugs Sales Market Share by Region in 2020
Figure 19. Global Acute Migraine Drugs Revenue Market Share by Region (2016-2021)
Figure 20. Global Acute Migraine Drugs Revenue Market Share by Region in 2020
Figure 21. U.S. Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Acute Migraine Drugs by Type (2016-2021)
Figure 46. Sales Market Share of Acute Migraine Drugs by Application (2016-2021)
Figure 47. Sales Market Share of Acute Migraine Drugs by Application in 2020
Figure 48. Revenue Share of Acute Migraine Drugs by Application (2016-2021)
Figure 49. Revenue Share of Acute Migraine Drugs by Application in 2020
Figure 50. Manufacturing Cost Structure of Acute Migraine Drugs
Figure 51. Manufacturing Process Analysis of Acute Migraine Drugs
Figure 52. Acute Migraine Drugs Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed